Ajanta Pharma Limited
AJANTPHARM
Rang in Aktien
#3707
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aktienkurs
$36.41
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$4.55B
Veränderung (1 Tag)
-0.54%
Veränderung (1 Jahr)
30.93%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Kategorie
Healthcare
P/S-Verhältnis für Ajanta Pharma Limited (AJANTPHARM)
P/S-Verhältnis zum October 2026 TTM: 7.22
Laut den neuesten Finanzberichten und dem Aktienkurs von Ajanta Pharma Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 7.22. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 6.70.
P/S-Verlauf für Ajanta Pharma Limited von 2005 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 7.22 | 2.45% |
| 2025 | 7.05 | 5.24% |
| 2024 | 6.70 | 61.85% |
| 2023 | 4.14 | -13.17% |
| 2022 | 4.77 | -13.04% |
| 2021 | 5.48 | 17.77% |
| 2020 | 4.65 | 3.04% |
| 2019 | 4.52 | -24.60% |
| 2018 | 5.99 | -25.91% |
| 2017 | 8.08 | 11.33% |
| 2016 | 7.26 | -2.23% |
| 2015 | 7.43 | 150.83% |
| 2014 | 2.96 | 77.93% |
| 2013 | 1.66 | 110.13% |
| 2012 | 0.79 | 70.54% |
| 2011 | 0.46 | -11.05% |
| 2010 | 0.52 | 203.72% |
| 2009 | 0.17 | -43.53% |
| 2008 | 0.30 | -6.40% |
| 2007 | 0.33 | -12.74% |
| 2006 | 0.37 | 11.05% |
| 2005 | 0.34 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -2.29% |
IN
|
